Our Subsidiaries Company, Aeskulap Clinic (Asia) Co.,ltd. held the Symposium about HIFU Cancer Treatment on Late January 2013 at The Royal Highness Princess Maha Chakri Sirindhorn Hospital, Srinakharinwirot University

AESKULAP Clinic (Asia) Co.,ltd held the symposium about how to use HIFU treat the cancer patients and opening the cancer center at The Royal Highness Princess Maha Chakri Sirindhorn Hospital for the research study project on 31 January - 1 February  2013. The symposium was about the Cancer and Tumor Therapy with the presentation of the research and case study of Dr. Hu Xiaoye and Dr. Liu, Li

from The Second Affiliated Hospital Zhejiang University School of Medicine who were the experienced doctor and researcher for HIFU Treatment more than 12 years to the audiences who were the certified doctor almost 100 doctors all over the country.  

AESKULAP CLINIC (ASIA) CO.,LTD has been establish the collaboration for The Cell Cultivation Research by using Robot Cultivate Cell Culture (R-CPX) which the R-CPX was granted from the Japanese Government through NEDO Ministry of International Trade and Industry (MITI) of Japan as co research project between Kawasaki Heavy Industry, Japan and DSP Research Co.,ltd. and Mukogawa Women's University and Faculty of Medicine, Chulalongkorn University and Faculty of Medicine, Srinakharintarawiroj University agrees on The Cell Cultivation Research by using Robot Cultivate Cell Culture (R-CPX).

Our Subsidiaries Company, Aeskulap Clinic (Asia) Co.,ltd. Signed the MOU with Department of Trade Negotiation (DTN),Ministry of Commerce of Thailand and NEDO, Ministry of International Trade and Industry (MITI) of Japan and Kawasaki Heavy Industry, Japan and DSP Research Co.,ltd. and Mukogawa Women's University and Faculty of Medicine, Chulalongkorn University and Faculty of Medicine, Srinakharintarawiroj University agrees on The Cell Cultivation Research by using Robot Cultivate Cell Culture (R-CPX) on 27 November 2012 at Ministry of Commerce, Thailand

Symposium

On September 30, 2013, HRH Princess Maha Chakri Sirindhorn graciously presided over the Grand Opening Ceremony of Experimental Laboratory for Automated Cell Culturing system at Faculty of Medicine, Chulalongkorn University.

 

The Laboratory was established under the collaboration between public and private sectors fromThailand and Japan. The Project was a result of an initial discussion between the Minister of Commerce of Thailand (Mr. Boonsong Triyapirom), Advisor to The Minister of Commerce of Thailand (Mr. Chisanupong Dhanakiccapavaraphan) and the Minister of economy, Trade and Industry of Japan (Mr. Yukio EDANO), during the official visit to Japan of Prime Minister Yingluk Chinawatra.

                        An MOU was later signed among Thai’s Teams (The Department of Trade Negotiations of Thailand (DTN), AESKULAP Clinic (Asia) Co., Ltd, Faculty of Medicine (Chulalongkorn University), Faculty of Medicine, Mahidol University, Faculty of Medicine (Srinakharinwiroj University), and Japanese’s Team, The New Energy and Industrial Technology Development Organization (NEDO) of Japan, Kawasaki Heavy Industries Limited, Osaka University Graduate School of Medicine,  DSPResearch Inc, School of Health and Sports Sciences, Mukogawa Women’s University to promote cooperative research and development on Regenerative and Cell-related Medical Technologies  between Thailand and Japan. According to the MOU, Kawasaki Heavy Industries Limited built a Robotic Cell Culturing System (RCPX) and donates to Thailand with financial support from NEDO.

On the part of Thailand, DTN and AESKULAP Clinic (Asia) Co., Ltd., are to be responsible for the implementation of the project. The R-CPX machine is installed at the Faculty of Medicine, Chulalongkorn University, while research partners in Thailand also include Srinakharinwirot University and Mahidol University.

 

After the opening, the GMP Laboratory for R-CPX is to open for visit by relevant personnel to observe the automated cell culturing system being developed in the project. It is expected that the promotion of the project would bolster Japan’s advanced regenerative and cell-related medical technologies and result in the contribution to further vitalize the medical industries of both Japan and Thailand.